Publications
Neurologic complications of acute hepatitis E virus infection.
Ripellino P, Pasi E, Melli G, Staedler C, Fraga M, Moradpour D, Sahli R, Aubert V, Martinetti G, Bihl F, Bernasconi E, Terziroli Beretta-Piccoli B, Cerny A, Dalton HR, Zehnder C, Mathis B, Zecca C, Disanto G, Kaelin-Lang A, Gobbi C
Neurol Neuroimmunol Neuroinflamm. 2020 Jan;7(1)
Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein.
Szkolnicka D, Pollán A, Da Silva N, Oechslin N, Gouttenoire J, Moradpour D
J Virol. 2019 Oct 1;93(19)
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
Fraga M, Gouttenoire J, Sahli R, Chtioui H, Marcu C, Pascual M, Moradpour D, Vionnet J
BMC Gastroenterol. 2019 May 24;19(1):76
Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland.
Sahli R, Fraga M, Semela D, Moradpour D, Gouttenoire J
J Hepatol. 2019 May;70(5):1023-1025
Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients.
Asgari S, Chaturvedi N, Scepanovic P, Hammer C, Semmo N, Giostra E, Müllhaupt B, Angus P, Thompson AJ, Moradpour D, Fellay J
J Viral Hepat. 2019 Feb;26(2):271-277
Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion.
Gouttenoire J, Pollán A, Abrami L, Oechslin N, Mauron J, Matter M, Oppliger J, Szkolnicka D, Dao Thi VL, van der Goot FG, Moradpour D
PLoS Pathog. 2018 Dec;14(12):e1007471
Glycogen Synthase Kinase 3β Enhances Hepatitis C Virus Replication by Supporting miR-122.
Saleh M, Rüschenbaum S, Welsch C, Zeuzem S, Moradpour D, Gouttenoire J, Lange CM
Front Microbiol. 2018;9:2949
Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs.
Saleh M, Welsch C, Cai C, Döring C, Gouttenoire J, Friedrich J, Haselow K, Sarrazin C, Badenhoop K, Moradpour D, Zeuzem S, Rueschenbaum S, Lange CM
J Steroid Biochem Mol Biol. 2018 Oct;183:142-151
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.
Fraga M, Doerig C, Moulin H, Bihl F, Brunner F, Müllhaupt B, Ripellino P, Semela D, Stickel F, Terziroli Beretta-Piccoli B, Aubert V, Telenti A, Greub G, Sahli R, Moradpour D
Liver Int. 2018 Apr;38(4):619-626
Targeting Endoplasmic Reticulum and/or Mitochondrial Ca<sup>2+</sup> Fluxes as Therapeutic Strategy for HCV Infection.
Scrima R, Piccoli C, Moradpour D, Capitanio N
Front Chem. 2018;6:73
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies.
Bartenschlager R, Baumert TF, Bukh J, Houghton M, Lemon SM, Lindenbach BD, Lohmann V, Moradpour D, Pietschmann T, Rice CM, Thimme R, Wakita T
Virus Res. 2018 Mar 15;248:53-62
Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.
Wu X, Dao Thi VL, Liu P, Takacs CN, Xiang K, Andrus L, Gouttenoire J, Moradpour D, Rice CM
Gastroenterology. 2018 Feb;154(3):663-674.e7
EASL Clinical Practice Guidelines on hepatitis E virus infection
European Association for the Study of the Liver
JOURNAL OF HEPATOLOGY
Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication.
Farhat R, Ankavay M, Lebsir N, Gouttenoire J, Jackson CL, Wychowski C, Moradpour D, Dubuisson J, Rouillé Y, Cocquerel L
Cell Microbiol. 2018 Jan;20(1)
CHUV
Rue du Bugnon 48
CH-1011 Lausanne, Suisse
+41 21 314 4056
CHUV
Rue du Bugnon 48
CH-1011 Lausanne, Suisse
+41 21 314 4056